AppMarketSpy › Medical › EndeavorOTC®: Outplay ADHD
EndeavorOTC®: Outplay ADHD
Proven Adult ADHD Treatment
Akili Interactive Labs, Inc. · Medical
★ 3.95average rating
1,657ratings
+1new ratings, last 7 days
#67Top Grossing · Medical
Ratings breakdown
| ★★★★★ | 63% | |
| ★★★★ | 10% | |
| ★★★ | 5% | |
| ★★ | 4% | |
| ★ | 18% |
🔒 Rating history23 days of daily rating and rating countGet Pro access
App info
- Developer
- Akili Interactive Labs, Inc.
- Category
- Medical, Health & Fitness
- Released
- Jun 6, 2023
- Version
- 4.0.1 (Feb 25, 2026)
- Price
- Free
- Size
- 683.5 MB
- Requires
- iOS 16.0
- Age rating
- 18+
- Languages
- English
In-app purchases
| Treatment Access | $129.99 |
| Treatment Access | $24.99 |
| Treatment access | $24.99 |
| Treatment Access | $99.99 |
| Treatment Access | $149.99 |
| Treatment access | $129.99 |
| Treatment Access | $129.99 |
| Treatment Access | $129.99 |
| Treatment Access | $179.99 |
| Early Access | $15.00 |
Current prices, App Store US.
🔒 Price history4 snapshots: when prices changed and new plans appearedGet Pro access
Top charts right now
| Top Grossing · Medical | #67 |
🔒 Chart rank history159 chart positions recorded, every 3 hoursGet Pro access
About EndeavorOTC®: Outplay ADHD
Start your subscription today to begin treatment with EndeavorOTC, the FDA-authorized, game-based ADHD treatment clinically designed to improve symptoms, attention and focus. The treatment includes Focus Score, a first-of-its-kind personalized metric where you can track attention progress. EndeavorOTC is for adults 18 years and older with ADHD experiencing inattention-related challenges that affect their quality of life such as diminished focus, inability to complete projects or tasks, keep track of important items, and more. Built with the same technology as EndeavorRx, the world's first FDA-authorized video game treatment. EndeavorOTC is available now by subscription. No prescription needed. EndeavorOTC was studied in more than 220 participants over a 6-week period. In the clinical trial, 88% of participants saw improvement in their attention and 73% of participants reported quality…
🔒 Developer intelligencelegal entity, account ID and every app from this sellerGet Pro access